Hwang convicted of fraud in cloning ruse
Labels: adult stem cells, bioethics, cloning
Human Life. Human Ethics. Since it looks like we're the only species having this conversation..... Common ground and catalyst for the protection of human rights in medicine and science policy.
Labels: adult stem cells, bioethics, cloning
Labels: adult stem cells, bioethics, cellular medicine, cloning, cybrids, embryonic stem cell, embryonic stem cells, hybrid, regenerative medicine, reprogrammed cells
Labels: adult stem cells, bioethics, cloning, embryonic stem cell, embryonic stem cells, iPS, IVF
Labels: bioethics, chimeras, cloning, embryonic stem cells, hybrid, medical ethics, public policy, regenerative medicine, research, research ethics, stem cell research, xenotransplant
The Stemagen scientists, led by Andrew French, an animal cloner recruited from Australia, used skin cells from Dr. Wood and another Stemagen employee as the DNA source. They used 29 eggs donated by young women at the fertility clinic that Dr. Wood manages.
Five blastocysts were developed. One was shown to be a clone by genetic testing, the scientists reported, and two others also showed good evidence of being clones.
Dr. Wood said the key to success might have been choosing egg donors who were known to be fertile and healthy because they had previously been successful donors at his fertility clinic.
The women were also donating at the same time to couples wanting babies. Some eggs went to the couples and the others to the research, with the consent of both the donors and the couples. The donors were paid for the eggs that went to the in vitro fertilization but not to the research, Dr. Wood said.
Therapeutic cloning has been hampered by lack of access to healthy eggs, in part because it is often considered unethical to pay women for such donations. Dr. Daley of Harvard said Stemagen’s “egg sharing” approach appeared to be a reasonable way to obtain eggs.
Labels: Artificial Reproduction, Assisted Reproduction, cloning, embryonic stem cells, stem cell research, stem cells
This study demonstrates, for the first time, that SCNT can be utilized to generate cloned human blastocysts using differentiated adult donor
nuclei remodeled and reprogrammed by human oocytes. Evidence of successful SCNT was shown with DNA fingerprinting analyses of three SCNT cloned blastocysts where embryo genomic DNA was that of the donor fibroblast cell line and were not fragmented oocytes or of parthenogenetic origin.
. . .DNA fingerprints from three SCNT blastocysts were consistent with those of the somatic cell donor employed with no evidence of contamination from the egg donors, indicating that embryonic development was being controlled by the donor cell genome.
Labels: Artificial Reproduction, Assisted Reproduction, bioethics, cloning, embryonic stem cells, stem cell research, stem cells
"Some people consider stem cell biology to be the Holy Grail of Regenerative Medicine, while others view embryonic stem cell use as morally wrong."
MYTH
Stem cell research uses aborted fetuses.
REALITY
Stem cells can be totipotent (a fertilized egg with the “total potential” to give rise to all different types of cells in the body), multipotent (stem cells that can give rise to a small number of different cell types), or pluripotent (stem cells that can give rise to any type of cells in the body except those that are needed to develop a fetus). While pluripotent stem cells could be developed from fetal tissue or even adults, they are best derived from early-stage embryos, a mass of cells that is only a few days old—not aborted fetuses.
MYTH
Somatic cell nuclear transfer using human cells involves the use of fertilized eggs.
REALITY
Somatic cell nuclear transfer, the process in which the nucleus from an adult cell is removed and then transferred to an egg whose nucleus has been removed, is the first step in cloning and can be used to create an embryonic stem cell line. However, an egg cell does not need to be fertilized to be used in this procedure—an unfertilized egg cell can be used.
MYTH
Researchers can use adult stem cells instead of embryonic stem cells. Other treatments using adult stem cells are available to treat conditions such as Parkinson's disease and spinal cord injuries.
REALITY
Adult stem cells lack the versatility and flexibility of embryonic stem cells, making them less likely to lead to medical breakthroughs. Embryonic stem cells have a far greater developmental potential and are more likely to be pluripotent, while adult stem cells are thought to be merely multipotent, or restricted to only certain cell types.
In November 2007, Japanese and American research teams reported new ways to obtain stem cells that behaved like embryonic stem cells from human skin cells—without having to use human embryos. This breakthrough holds great promise in solving the ethical dilemmas of stem cell research, but scientists currently still face technical hurdles and the challenge of finding ways to use these stem cells successfully in medical treatments and therapies.
Labels: adult stem cells, bioethics, cloning, embryonic stem cells, public policy, stem cell research, taxpayer funds, umbilical cord stem cells

Researchers found a way to clone pet cats five years ago. Now they can play a trick on their genes to change their color.
A Gyeongsang National University team said they have succeeded in cloning cats after modifying a gene to change their skin color. Because of the red fluorescence protein in their skin cells, the three Turkish Angola kittens look reddish under ultraviolet light, the researchers said.
The red cloned cat research is expected to be utilized in dealing with certain genetic diseases in animals and humans. It will also help reproduce rare animals, such as tigers and wildcats, which are on the verge of extinction, the team said.
According to the team led by professor Kong Il-keun, four kittens were born in January and February by caesarian section, but one died during the procedure. They weighed between 110 and 136 grams at birth and now weigh 3.5 kilograms each now, the researchers said.
``We have proved our world-class ability in cloning animals that have modified characteristics,'' said Kong. ``We found that the red fluorescent protein in all the organs of the dead kitten, which means we have established an efficient way of cloning gene-modified cats.''
The first cloned cat, nicknamed Copycat, was born in 2002 at Texas A&M University. Many other animals such as cows, dogs, pigs, bulls and goats have been successfully cloned by a number of researchers in North America, Europe and South Korea.
Kong cloned a cat in 2004 for the first time in the country. He has since worked as director of research at a state-supported project to clone animals for therapeutic research.
To clone the Turkish Angola cats, Kong's team used skin cells of the mother cat. They modified its genes to make them fluorescent by using a virus, which was transplanted into the ova. The ova were then implanted into the womb of the donor cat.
Called reproductive cloning, the method has been mostly used in cloning animals that are genetically identical, until Kong's kittens were born with the tampered genes.
The technique differs from therapeutic cloning, which is to make a ``stem cell'' that can be guided to grow into a specific body part. Former Seoul National University professor Hwang Woo-suk used this method in his human stem cell cloning research, which was later found to have used fabricated data.
Actually, human ES cells (unlike mouse ES cells) are perfectly capable of differentiating into trophoblast (Nature Biotech 20:1261; 2002). Why do you think this isn't common knowledge? (Hint: politics) And mouse ES cells can be turned into whole mice quite efficiently with a technique that does NOT involve blastocyst injection or tetraploid embryos (Nature Biotech 25:91; 2007). Concerning your next post, how do you know what the intent was behind naming these cells iPS cells?
The question is whether continued research will soon get us to the point where fibroblasts cells can be transformed into cells that are completely indistinguishable from human ES cells, with the potential to form every human cell type (including, eventually, blastomeres which could, in theory, develop into babies without any further "tinkering"). With all of the accomplishments of the last ten years, it is very hard to imagine that this won't be possible. The ONLY reason to doubt it is based on a religious-inspired faith that there is something FUNDAMENTALLY different between blastomeres and ES cells.
Labels: adult stem cells, bioethics, cloning, embryonic stem cell, embryonic stem cells, induced pluripotent stem cells, iPS, politics, public policy, research ethics
Both labs in the news actually showed their final process using adult cells that did not require the death of any human individual at any age.
However, one of the groups (Thomson's, from Wisconsin) proved that the process is possible by using embryonic stem cells and fetal cells from abortions, while the other group (Yamanaka's, from Japan) used mouse cells for the basic science before using adult skin cells.
It can get complicated, and you do have to read "the fine print" in the reports to figure out the source.
I've always thought of the two groups as divided into
1. Destructive Research - that depends on the intentional destruction of individual human beings at any age is unethical vs.
2. Non-destructive Research - ethical research methods that do not intentionially cause injury to human beings.
For simplicity, most people call the first "embryonic" and the others "adult."
For instance, umbilical and amniotic fluid cells are ethical, non-destructive stem cells that are technically "fetal stem cells."
In contrast,
1. "embryonic" means the cells came from embryos - in humans that's up to 8 weeks gestation.
2. Most of the "fetal cells" used in research come from harvesting the bodies of children who are aborted, between the age of 8 weeks and term. These are sold as tissue cultures by commercial labs. Some of the cultures have been cultivated for 20 or 30 years and the genes and growth habits have been studied and they can be counted on to do what they are supposed to do.
3. Sometimes the "fetal" tissues are harvested after a natural miscarriage. These are considered ethical. (I don't think there are any commercially available standard tissue cultures from miscarriages.)
Usually name is based on where the cells came from, but if the cells acted like the very early embryo - if they were truly "totipotent" like the zygote which is able to make both the body and the placenta - then research on them would be unethical.
The problem with "therapeutic" cloning, for instance, is that it would create a new human embryo that is capable of self-directed, organized development.
Even if he or she will be killed or die naturally in a few days, it's not right to create human beings with the intention of destroying them or using them for the benefit of others and to their own harm.
I agree. We believe that "self-" should always be part of "sacrifice."
Labels: adult stem cells, bioethics, cloning, embryonic stem cells, induced pluripotent stem cells, iPS, philosophy, politics, public policy
Labels: adult stem cells, bioethics, cloning, embryonic stem cells, research, stem cells
WASHINGTON (Reuters) - Two separate teams of researchers announced on Tuesday they had transformed ordinary skin cells into batches of cells that look and act like embryonic stem cells -- but without using cloning technology and without making embryos.
Their breakthroughs could make possible the long-sought goal of tailor-made medicine, but without the political, scientific and ethical roadblock of using human embryos.
Both teams call the new cells induced pluripotent stem cells and say they look and act like embryonic stem cells -- the master cells that give rise to every cell and tissue in the body.
. . .
James Thomson of the University of Wisconsin in Madison and colleagues reported their finding in the journal Science while Shinya Yamanaka of Kyoto University in Japan and colleagues reported theirs in the journal Cell.
Labels: adult stem cells, bioethics, cloning, embryonic stem cells, public health, public policy, regenerative medicine, research ethics, stem cells
This approach, he says, represents, the future for stem cell research, rather than the nuclear transfer method that his large team used more than a decade ago at the Roslin Institute, near Edinburgh, to create Dolly.
1. No one has been able to clone a human embryo in spite of thousands of eggs used in Hwang's scam alone,
2. That 13,000 monkey eggs were used in the latest attempt to clone primates, that the published study relates an efficiency of 0.7% success, and the authors aren't quite sure why they were successful where other labs weren't,
3. The fact that true embryonic stem cells are short lived in the body and difficult to control (reports actually criticized the embryonic like stem cells from dedifferentiation for making tumors in mice - although that is one of the properties that defines embryonic stem cells)
4. That transfection with plasmids and specialized virus particles is an established technique of gene therapy,
5. and that the production of stem cell lines toward the end-stage adult cells has used viral transfection as well.
Labels: adult stem cells, bioethics, cloning, embryonic stem cells, gene therapy, philosophy, public policy, regenerative medicine
A technical breakthrough has enabled scientists to create for the first time dozens of cloned embryos from adult monkeys, raising the prospect of the same procedure being used to make cloned human embryos.
Attempts to clone human embryos for research have been dogged by technical problems and controversies over fraudulent research and questionable ethics. But the new technique promises to revolutionise the efficiency by which scientists can turn human eggs into cloned embryos.
It is the first time that scientists have been able to create viable cloned embryos from an adult primate – in this case a 10-year-old male rhesus macaque monkey – and they are scheduled to report their findings later this month.
The scientists will also demonstrate that they have been able to extract stem cells from some of the cloned embryos and that they have managed to encourage these embryonic cells to develop in the laboratory into mature heart cells and brain neurons.
Scientists who know of the research said it was the breakthrough that they had all been waiting for because, until now, there was a growing feeling that there might be some insuperable barrier to creating cloned embryos from adult primates – including humans.
*****
The Oregon team, working with a group in China, has so far produced about 100 cloned embryos that have been transferred into around 50 female macaques, but none has resulted in a full-term pregnancy, he said.
"It's possible that we're still just having bad luck. We're producing may be one in 20 or one in 30 cloned blastocysts that are 'normal' and capable of producing a pregnancy and we just haven't got them into the animal recipient at the right time to allow implantation and pregnancy to occur," Professor Wolf said.
"The focus now is going to be on therapeutic cloning and using the non-human primate as a paradigm for therapeutic cloning for what you might be able to do clinically," he said.
"We're the first to do it, although it's a tainted subject because of the fraudulent research that came out of South Korea. One can never be sure but there may be some validity to what the South Koreans did. But this would now be the first documented therapeutic cloning in a primate," he added.
A brief history of cloning
The monkey-cloning technique is the same basic procedure that resulted in Dolly the sheep. The nucleus of a healthy, unfertilised egg is removed and another nucleus from the mature skin cell of an adult animal is placed inside the egg. With careful timing and the use of electrical pulses, an embryo can be created which is a genetic clone of the skin tissue donor. It is possible to implant embryos created in this way into the womb to produce cloned animals. This so-called 'reproductive cloning' of humans is illegal in Britain and many other countries. However it has been applied to a range of animal species, including:
* Cow: Many domestic cattle have been successfully cloned. First attempt to clone an endangered species was Noah, a rare gaur ox, which was cloned in the US in 2001 but died 48 hours after birth
* Mouse: Cumulina was a common brown house mouse, cloned from adult cells at the University of Hawaii in 1997. She survived to adulthood and produced two litters, before dying in May 2000
* Horse: Called Prometea, the first cloned horse, born in Italy in May 2003
* Cat: A kitten called CopyCat was born in 2002 in Texas, and gave birth to three kittens by a natural father in September 2006
* Dog: Snuppy, born in South Korea. Doubts about its authenticity were dispelled by DNA tests. The group has also cloned two wolf cubs, called Snuwolf and Snuwolffy using the same procedure. Cloned Afghan hounds named Bona, Peace and Hope have also been born.
Labels: Artificial Reproduction, bioethics, cloning, embryonic stem cell, regenerative medicine, stem cells
Labels: adult stem cells, bioethics, cloning, embryonic stem cells, regenerative medicine, research ethics, research finance, Texas research, umbilical cord stem cells
In mild and moderate cases, affecting up to 20% of women undergoing ovary stimulation, this leads to symptoms such as swelling and breathlessness that resolves.
However, in about 1% the symptoms can become so severe that they are deadly. Among women with PCOS [Polycystic Ovarian Syndrome], the rate is nearer 5-10%.
Labels: Artificial Reproduction, Assisted Reproduction, bioethics, cloning, embryonic stem cells, fertility, research ethics, Women's Health
Disgraced Korean Cloner Blew It: He Did Make History
A new report by a team of US researchers says the human embryonic stem cells generated in a now-discredited experiment in South Korea, actually were a first. When Woo Suk Hwang announced three years ago he had created the first human patient-specific ESC, he was hailed as a science hero.
He said he did it with a cloning technique called somatic cell nuclear transfer, a tricky process in which a nucleus is inserted into a cell. Last year he and other researchers were fired after it turned out they fabricated data. But now, Harvard scientists say analysis of Hwang’s embryos show they were in fact the first-ever human cells created by parthenogenesis, virgin birth. The multiplying cells were the result of an egg alone.
The kicker is the Korean team had apparently hit upon a technique that scientists say could have resulted in a major advance for stem cell research, and were years ahead of anyone else. Had they been truthful, Hwang and colleagues might still be heroes, and embryonic stem cell therapies would be that much closer to reality.
Labels: bioethics, cloning, parthenogenesis
Labels: bioethics, cloning, embryonic stem cells, life decisions, medical ethics, public policy
Congress has sent me a bill that would overturn this policy. If this legislation became law, it would compel American taxpayers -- for the first time in our history -- to support the deliberate destruction of human embryos. I made it clear to Congress and to the American people that I will not allow our nation to cross this moral line. Last year, Congress passed a similar bill -- I kept my promise by vetoing it. And today I'm keeping my word again: I am vetoing the bill that Congress has sent. (Applause.)
Destroying human life in the hopes of saving human life is not ethical -- and it is not the only option before us.
Labels: bioethics, chimeras, cloning, embryonic stem cells, media bias, medical ethics, public policy, regenerative medicine, stem cells
Nature advance online publication 6 June 2007 | doi:10.1038/nature05934; Received 6 February 2007; Accepted 22 May 2007; Published online 6 June 2007
Generation of germline-competent induced pluripotent stem cells
Keisuke Okita1, Tomoko Ichisaka1,2 & Shinya Yamanaka1,2
1. Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
2. CREST, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan
Correspondence to: Shinya Yamanaka1,2 Correspondence and requests for materials should be addressed to S.Y. (Email: yamanaka@frontier.kyoto-u.ac.jp).
We have previously shown that pluripotent stem cells can be induced from mouse fibroblasts by retroviral introduction of Oct3/4 (also called Pou5f1), Sox2, c-Myc and Klf4, and subsequent selection for Fbx15 (also called Fbxo15) expression. These induced pluripotent stem (iPS) cells (hereafter called Fbx15 iPS cells) are similar to embryonic stem (ES) cells in morphology, proliferation and teratoma formation; however, they are different with regards to gene expression and DNA methylation patterns, and fail to produce adult chimaeras. Here we show that selection for Nanog expression results in germline-competent iPS cells with increased ES-cell-like gene expression and DNA methylation patterns compared with Fbx15 iPS cells. The four transgenes (Oct3/4, Sox2, c-myc and Klf4) were strongly silenced in Nanog iPS cells. We obtained adult chimaeras from seven Nanog iPS cell clones, with one clone being transmitted through the germ line to the next generation. Approximately 20% of the offspring developed tumours attributable to reactivation of the c-myc transgene. Thus, iPS cells competent for germline chimaeras can be obtained from fibroblasts, but retroviral introduction of c-Myc should be avoided for clinical application.
Although ES cells are promising donor sources in cell transplantation therapies1, they face immune rejection after transplantation and there are ethical issues regarding the usage of human embryos. These concerns may be overcome if pluripotent stem cells can be directly derived from patients' somatic cells2. We have previously shown that iPS cells can be generated from mouse fibroblasts by retrovirus-mediated introduction of four transcription factors (Oct3/4 (refs 3, 4), Sox2 (ref. 5), c-Myc (ref. 6) and Klf4 (ref. 7)) and by selection for Fbx15 expression8. Fbx15 iPS cells, however, have different gene expression and DNA methylation patterns compared with ES cells and do not contribute to adult chimaeras. We proposed that the incomplete reprogramming might be due to the selection for Fbx15 expression, and that by using better selection markers, we might be able to generate more ES-cell-like iPS cells. We decided to use Nanog as a candidate of such markers.
Although both Fbx15 and Nanog are targets of Oct3/4 and Sox2 (refs 9–11), Nanog is more tightly associated with pluripotency. In contrast to Fbx15-null mice and ES cells that barely show abnormal phenotypes9, disruption of Nanog in mice results in loss of the pluripotent epiblast12. Nanog-null ES cells can be established, but they tend to differentiate spontaneously12. Forced expression of Nanog renders ES cells independent of leukaemia inhibitory factor (LIF) for self-renewal12, 13 and confers increased reprogramming efficiency after fusion with somatic cells14. These results prompted us to propose that if we use Nanog as a selection marker, we might be able to obtain iPS cells displaying a greater similarity to ES cells.
Labels: adult stem cells, bioethics, cloning, embryonic stem cell, embryonic stem cells, legislation, medical ethics, medical technology, politics, public policy, regenerative medicine
Labels: bioethics, cloning, embryonic stem cell, medical ethics, politics, public policy, stem cells, Texas Advance Directive Act, umbilical cord stem cells
Friday's vote came after a committee meeting that began Thursday and lasted through the night. Critics said the vote came hours after testimony concluded and while the committee was focused on an unrelated bill.
"Those of us who rely on the hope stem cell research holds, and anyone who cares about an open public dialogue, should be outraged at the manner in which the vote was taken on Friday afternoon — without discussion and while two members opposed to the bill were absent," said Judy Haley, president of Texans for the Advancement of Medical Research.
Kathy Miller, president of the Texas Freedom Network, called the vote's timing a "sneak attack."
"It's a shameful case of putting politics ahead of science as well as patients and their families," she said.
By: Paxton, Olivo, Christian, Chisum, Parker, H.B. No. 225 et al.
A BILL TO BE ENTITLED AN ACT
relating to prohibiting the use of state money for certain
biomedical research.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Subtitle H, Title 2, Health and Safety Code, is amended by adding Chapter 169 to read as follows:CHAPTER 169. BIOMEDICAL RESEARCH
Sec. 169.001. PROHIBITION ON USE OF STATE MONEY FOR CERTAIN BIOMEDICAL RESEARCH. A person may not use state money for biomedical research if federal law prohibits the use of federal money for that research on January 1, 2007.
SECTION 2. This Act takes effect September 1, 2007.
Labels: bioethics, cloning, embryonic stem cells, legislation, politics, public policy, research finance, stem cells, umbilical cord stem cells, Yellow Brick Award
Apr 12, 2007
Stem-cell reversal
Scrap Romney restrictions on legitimate research
Gov. Deval L. Patrick’s effort to reverse restrictions on stem-cell research imposed by his predecessor is most welcome.
The restrictions, adopted by the state Public Health Council, are in direct opposition to 2005 legislation, enacted over former Gov. Mitt Romney’s veto, that permits human embryonic stem-cell research in the state. The former governor was opposed to the provision in the law that allowed for “somatic cell nuclear transfer.” The technique gives researchers a new way to study the development of a particular disease because the stem cells are created from the DNA of patients who suffer from that disease. Just this week, researchers reported that 13 young diabetics in Brazil being treated with their own stem cells are living insulin-free, some for as long as three years.
Make no mistake: Exacting and consistent guidelines must apply to research using stem cells. Human cloning already is banned in Massachusetts, a prohibition enforced by strong criminal and civil penalties. The law passed in 2005 also limits to two weeks of development the time during which embryonic stem cells could be harvested for research or treatment of patients. (Emphasis mine)
Labels: bioethics, cloning, embryonic stem cells, research finance, stem cells
Opponents argue that the research is unethical, because deriving the stem cells destroys the blastocyst, an unimplanted human embryo at the sixth to eighth day of development.
WASHINGTON (Reuters) - Stem cells will be at the top of the agenda for the U.S. Senate when it returns on Tuesday with supporters of the research hoping they can change the president's mind on the issue and opponents hoping to have a say about their stand.
. . ."We got a super-majority under the Republican-controlled 109th Congress," said Sean Tipton of the American Society of Reproductive Medicine, which lobbies in support of embryonic stem-cell research.
Tipton said the current Democratic-controlled Senate will be even friendlier. "When the Senate passes this bill, the president is going to be under incredible pressure to acknowledge that the science has changed and to acknowledge that the American people support this research," he said in a telephone interview.
"The bill is a Trojan Horse. It contains language directing the Secretary of HHS "to conduct and support basic and applied research having pluripotent potential" so long as "That the isolation, derivation, production, or testing of such cells will not involve-(1) the creation of a human embryo or embryos for research purposes"
SCNT involves just such technique. The clear implication is that under this language SCNT is "unethical." Passage of this bill would make the day for NIH funding of SCNT difficult or impossible."
Labels: bioethics, cloning, embryonic stem cells, public health, public policy, stem cells, umbilical cord stem cells
Joining the cloning experts in the race are scientists who are looking for new ways to "reprogram" DNA, or make it young again without fusing it into an egg. They think it may be possible, for example, to bathe adult cells in the right chemicals and produce stem cells.
"In my view, it is difficult to predict which will come first but I think we need to try both," Wilmut said Tuesday. "If I had to bet money, I would probably bet on reprogramming" rather than cloning.
The science of reprogramming, he said, is moving quickly, and scientists working in the field don't have to deal with the myriad obstacles facing cloning.
Wilmut and other scientists want to obtain personalized embryonic cells by fusing DNA from, say, a skin cell into an egg with its own nucleus removed. The resulting cells could be used to study a host of difficult-to-research diseases and in theory could be used to repair damaged tissue in many ailments.
Researchers who received Connecticut's first batch of stem cell grants were among the scientists who presented their work at StemConn07.
Some of that work involves reprogramming the DNA of adult cells to produce embryonic stem cells tailored to a particular organism. This would have potentially huge implications for using a patient's own cells to repair damaged tissue without fear of rejection.
Success would quiet ethical objections to research that creates and/or destroys human embryos. Questions surrounding these techniques have resulted in a freeze on federal funding for work on stem cells created after Aug. 9, 2001.
Labels: cloning, embryonic stem cells, public policy, research finance, technology, umbilical cord stem cells
Labels: bioethics, cloning, embryonic stem cells, stem cells, Women's Health
Labels: bioethics, cloning, diabetes, embryonic stem cells, ethics for sale, insulin, medical ethics, politics, public policy, regenerative medicine, stem cells, Texas research, umbilical cord stem cells
Labels: bioethics, cloning, embryonic stem cell, embryonic stem cells, politics, Texas research, umbilical cord stem cells
Labels: cloning, Free Stuff, General, research
The team, headed by Koo Deog-bon at the Korea Research Institute of Bioscience and Biotechnology, said Friday they had established a monkey blastocyst, the source of stem cells, last month via interspecies nuclear transfer.
``We started the task of infusing monkey somatic cells into cow ova, from which the nuclei had been removed, last November. After hundreds of failures, we made a blastocyst in January,'' Koo said.
``It failed to thrive. But we became sure of the potential of interspecies research _ creating a blastocyst and extracting stem cell batches from it,'' the 41-year-old senior researcher said.
A blastocyst is an embryonic form at a stage where it consists of 128 cells. With its inner cells still undifferentiated, the blastocyst is the most important source of embryonic stem cells.
Scientists have made monkey blastocysts through intra-species nuclear transfer _ implanting monkey somatic cells into enucleated monkey ova. But this is the first time that a blastocyst has been established while using non-monkey ova.
``We will generate more monkey blastocysts to achieve our goals of culturing stem cell lines with them earlier than our competitors,'' said Koo at the state-backed institute.
Developing cloned non-human primate stem cells is significant in speeding up futuristic therapy by evaluating the pre-clinical safety and immune-tolerance of stem cell transplantation.
``If we are successful, we will be able to apply the technologies to humans _ making stem cells with animal ova _ if society allows such an idea,'' Koo said.
As Koo pointed out, the interspecies experiments can in part solve some of the ethical debates surrounding the making of cloned human embryonic stem cells because they don't use human eggs.
Labels: bioethics, chimeras, cloning, embryonic stem cell, hybrid, regenerative medicine, research, research finance, stem cells
Labels: abortion, bioethics, cloning, conscience, debates, embryonic stem cells, end of life, ethics for sale, eugenics, euthanasia, human rights, medical ethics, morals, philosophy, politics, public policy